Zamira Australia has raised US$2.4 million via a rights issue to existing and new investors
Zamira Australia has raised funds to support its expansion strategy.
Zamira is an Australian animal health brand whose mission is to improve the health, wellbeing and productivity of animals across the world. The company is favorably positioned as a premium brand with localized understanding and expertise — a trusted and strong Australian brand identity among its international competitors. The company maintains a key manufacturing partnership with global leader Bioproton which enables speed-to-market and continued improvement of their product range.
Oaklins’ team in Australia acted as corporate advisor in this transaction.
CEO, Zamira Australia
Sprechen Sie mit dem Deal Team
Managing DirectorMelbourne, Australien
Laptaria cu Caimac has raised growth capital
Laptaria cu Caimac has raised US$3.5 million via a corporate bond private placement that has attracted strong interest both from high-net-worth individuals and institutional investors.Mehr erfahren
Evolem has acquired a majority stake in Cap Vert
Evolem has acquired a majority stake in Cap Vert Développement Group (Cap Vert).Mehr erfahren
SKIOLD A/S has acquired Rotecna S.A.U.
Combining SKIOLD and Rotecna delivers clear strategic benefits to both companies, including a stronger global footprint and an enhanced platform to grow in new markets, a broader product portfolio of leading technologies and increased scale to support investments in R&D, such as digital solutions. Rotecna joins SKIOLD’s existing pig business unit, nearly doubling its size in terms of revenue. With this acquisition, SKIOLD Group’s revenue is approaching €200 million (US$235 million).Mehr erfahren